Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole Therapeutic Drug Monitoring in Renal Transplant Patients
ChiCTR-IPR-16008277Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of voriconazole in mycoses and kidney allograft rejection (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Blood concentration, Clinical index and 1 more. Started Apr 2016; status: recruiting.
02
Drugs
voriconazole
03
Conditions
mycoseskidney allograft rejection
Beyond the preview
Go deeper on ChiCTR-IPR-16008277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008277.